ERBB2 and colorectal carcinoma: Mechanistically, we discovered that NSUN2, independent of its m5C enzymatic activity, interacted with Cullin‐4B (CUL4B) to activate the EGFR/HER2‐STAT3 pathway, thereby promoting the malignant phenotype of CRC.